Skip to main content

Table 6 Effect of treatment at first 15 weeks comparing sulforaphane (SF) and placebo (PL) groups

From: Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder

Biomarker

SF (exposure)

PL (non-exposure)

N

F-statistic

p value

N

F-statistic

p value

Free reduced GSHa

22

1.51

0.232

23

0.11

0.746

Total GSHa

22

0.00

0.945

23

0.08

0.776

GSSGa

22

1.97

0.175

23

0.46

0.505

Free GSH:GSSG

22

12.72

0.002

23

0.87

0.361

Total GSH:GSSG

22

5.16

0.034

23

0.03

0.875

  1. Bold signifies p < 0.05
  2. MANOVA test used for repeated measures (compared to baseline at 0 weeks)
  3. aNatural log transformed
Back to article page

Molecular Autism

ISSN: 2040-2392